Nkgen Biotech Inc (NKGN)

Dec 12, 2024

NKGen Biotech Awards Stock Options to Executives - TipRanks

Dec 12, 2024

Dec 05, 2024

Head to Head Survey: HilleVax (NASDAQ:HLVX) versus NKGen Biotech (NYSE:NKGN) - Defense World

Dec 05, 2024

Dec 04, 2024

NKGen Biotech faces Nasdaq delisting over market value By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 04, 2024

NKGen Biotech faces Nasdaq delisting over market value - Investing.com

Dec 04, 2024

Dec 02, 2024

NKGen Biotech Selected as Stalking Horse Bidder for NKMax - GlobeNewswire

Dec 02, 2024

Dec 02, 2024

NKGen Biotech Secures $18M Bid for NKMax Acquisition, Expanding Global IP Rights - StockTitan

Dec 02, 2024

Nov 27, 2024

NKGen Biotech faces Nasdaq compliance issue By Investing.com - Investing.com Canada

Nov 27, 2024

Nov 26, 2024

NKGen Biotech faces Nasdaq compliance issue - Investing.com India

Nov 26, 2024

Nov 26, 2024

NKGen Biotech Receives Notifications From Nasdaq… - Inkl

Nov 26, 2024

Nov 26, 2024

NKGen Biotech Receives Notifications From Nasdaq Related to - GlobeNewswire

Nov 26, 2024

Nov 26, 2024

NKGen Biotech Receives Nasdaq Non-Compliance Notice, Granted Extension for Q3 Filing | NKGN Stock News - StockTitan

Nov 26, 2024

Nov 18, 2024

OC500 2024: Paul Y. Song - Orange County Business Journal

Nov 18, 2024

Nov 14, 2024

NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Financial Contrast - Defense World

Nov 14, 2024

Nov 11, 2024

NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire

Nov 11, 2024

Nov 08, 2024

Midday Stock Roundup: Indie Semiconductor Up 43% - Orange County Business Journal

Nov 08, 2024

Oct 29, 2024

NKGen Flat on Presentation of Alzheimer's Treatment - Baystreet.ca

Oct 29, 2024

Oct 29, 2024

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference - The Manila Times

Oct 29, 2024

Oct 29, 2024

NKGen Biotech Presents Phase 1/2a Troculeucel Data in - GlobeNewswire

Oct 29, 2024

Oct 29, 2024

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference - StockTitan

Oct 29, 2024

Oct 24, 2024

NKGen Biotech avoids Nasdaq delisting with regained compliance - Investing.com India

Oct 24, 2024

Oct 18, 2024

Dow Falls Over 100 Points; Netflix Posts Upbeat ResultsCatheter Precision (AMEX:VTAK) - Benzinga

Oct 18, 2024

Oct 16, 2024

Navigating NKGN Stock: NKGen Biotech Inc Journey - The InvestChronicle

Oct 16, 2024

Oct 16, 2024

Post-Trade Analysis: NKGen Biotech Inc (NKGN) Slides -6.54, Closing at 0.23 - The Dwinnex

Oct 16, 2024

Oct 15, 2024

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024) - The Manila Times

Oct 15, 2024

Oct 10, 2024

NKGen Biotech undergoes dilutive stock issuance By Investing.com - Investing.com Canada

Oct 10, 2024

Oct 10, 2024

NKGen Biotech undergoes dilutive stock issuance - Investing.com India

Oct 10, 2024

Oct 08, 2024

NKGN stock touches 52-week low at $0.35 amid market challenges - Investing.com Australia

Oct 08, 2024

Oct 08, 2024

NKGen Biotech Announces Poster Presentations at the 17th - GlobeNewswire

Oct 08, 2024

Oct 08, 2024

NKGen Biotech Announces Poster Presentations at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference - StockTitan

Oct 08, 2024

Oct 07, 2024

Market Watch Highlights: NKGen Biotech Inc (NKGN) Ends on an Upturn Note at 0.40 - The Dwinnex

Oct 07, 2024

Oct 04, 2024

NKGen Biotech directors resign after a year of service By Investing.com - Investing.com Australia

Oct 04, 2024

Oct 04, 2024

NKGen Biotech appoints new directors to its board By Investing.com - Investing.com South Africa

Oct 04, 2024

Oct 04, 2024

NKGen Biotech appoints new directors to its board - Investing.com India

Oct 04, 2024

Oct 04, 2024

NKGen Biotech Welcomes New Directors and Assigns Committees - TipRanks

Oct 04, 2024

Oct 03, 2024

NKGen Biotech directors resign after a year of service - Investing.com India

Oct 03, 2024

Oct 03, 2024

NKGen Biotech Announces Leadership Shuffle on Anniversary - TipRanks

Oct 03, 2024

Sep 28, 2024

NKGen Biotech faces potential Nasdaq delisting By Investing.com - Investing.com South Africa

Sep 28, 2024

Sep 27, 2024

NKGen Biotech faces potential Nasdaq delisting - Investing.com

Sep 27, 2024

Sep 27, 2024

Midday Stock Roundup: Indie Shares Down 5% - Orange County Business Journal

Sep 27, 2024

Sep 24, 2024

Analysts agree that Kenvue's Neutrogena needs a face-lift (KVUE) - Seeking Alpha

Sep 24, 2024

Sep 24, 2024

Nkarta Inc (NKTX)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Sep 24, 2024

Sep 23, 2024

Top investors say Krystal Biotech Inc (KRYS) ticks everything they need - SETE News

Sep 23, 2024

Sep 23, 2024

Investor’s Delight: Krystal Biotech Inc (KRYS) Closes Weak at 184.17, Down -0.17 - The Dwinnex

Sep 23, 2024

Sep 23, 2024

Market Momentum Report: Nkarta Inc (NKTX)’s Negative Close at 5.21 - The Dwinnex

Sep 23, 2024

Sep 23, 2024

Raymond James Upgrades Nkarta Inc (NKTX) to a Strong buy from an Outperform - Knox Daily

Sep 23, 2024

Sep 23, 2024

70,000 Shares in Neurogene Inc. (NASDAQ:NGNE) Purchased by Integral Health Asset Management LLC - Defense World

Sep 23, 2024

Sep 21, 2024

Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble? - Insider Monkey

Sep 21, 2024